Glucose dehydrogenase

ABSTRACT

A modified pyrroloquinoline quinone glucose dehydrogenase that exhibits a high selectivity for glucose is provided. A modified pyrroloquinoline quinone glucose dehydrogenase is disclosed in which the amino acid residue G at Position 99 of a pyrroloquinoline quinone glucose dehydrogenase (PQQGDH) represented by SEQ ID NO: 1, or the amino acid residue G at Position 100 of the pyrroloquinoline quinone glucose dehydrogenase (PQQGDH) represented by SEQ ID NO: 3, is substituted by the amino acid sequence TGZN (where Z is SX, S, or N and X is any amino acid residue). The modified PQQGDH of the present invention may additionally comprise one or more mutations selected from the group consisting of Q192G, Q192A, or Q192S; L193X; E277X; A318X; Y367A, Y367F, or Y367W; G451C; and N452X (where X is any amino acid residue).

TECHNICAL FIELD

The present invention relates to a pyrroloquinoline quinone-dependentglucose dehydrogenase (PQQGDH) and to its preparation and use in theglucose assay.

BACKGROUND ART

The blood glucose level is an important marker for diabetes. The use ofPQQGDH has already been commercialized as one method for measuring theglucose concentration.

PQQGDH is a glucose dehydrogenase that employs pyrroloquinoline quinoneas a coenzyme, and it catalyzes the oxidation of glucose with theproduction of gluconolactone. PQQGDH is known to occur as amembrane-bound enzyme and as a water-soluble enzyme. Membrane-boundPQQGDHs are single peptide proteins with molecular weights ofapproximately 87 kDa and are widely encountered in various Gram-negativebacteria. Water-soluble PQQGDH, on the other hand, has been identifiedin several strains of Acinetobacter calcoaceticus, and its structuralgene was cloned and its amino acid sequence was determined (GenBankaccession number X15871; Mol. Gen. Genet. (1989), 217: 430-436). Theresults of X-ray crystal structural analysis of water-soluble PQQGDHfrom Acinetobacter calcoaceticus have been reported and the higher orderstructure of the enzyme, and most importantly the active center, hasbeen elucidated. (A. Oubrie et al., J. Mol. Biol., 289, 319-333 (1999);A. Oubrie et al., The EMBO Journal, 18(19), 5187-5194 (1999); A. Oubrieet al., PNAS, 96(21), 11787-11791 (1999)). Water-soluble PQQGDH fromAcinetobacter baumannii has also been identified (GenBank accessionnumber E28183).

PQQGDHs have a high oxidation activity for glucose and do not requireoxygen as an electron acceptor because they are coenzyme-linked enzymes.As a result they are expected to find application in glucose assays andparticularly as the recognition element of glucose sensors. A problemwith PQQGDHs, however, is their low selectivity for glucose. Inparticular, PQQGDH also has a high activity for maltose, and thusaccurate assay is difficult in patients receiving a maltose-containinginfusion solution. In this case, the apparent blood sugar level will behigher than the actual blood sugar level, which could lead to a risk ofhypoglycemia caused by administering insulin to the patient based on themeasured level. Accordingly, a PQQGDH that exhibits a higher selectivityfor glucose versus maltose is desired for the enzyme used formeasurement of the blood sugar level.

The present inventor has already reported several modified PQQGDHs thatexhibit an increased selectivity for glucose (for example, WO 00/66744,Japanese Patent Application Laid-open No. 2001-346587, and WO2004/005499), but a modified PQQGDH that exhibits an even higherselectivity and/or an even higher enzymatic activity is still required.

The reference documents cited herein are listed below. The contents ofthese documents are hereby incorporated by reference in its entirety.None of these documents are admitted to constitute a prior art of thepresent invention.

-   Patent Document 1: WO 00/66744-   Patent Document 2: Japanese Patent Application Laid-open No.    2001-346587-   Patent Document 3: WO 2004/005499-   Nonpatent Document 1: Mol. Gen. Genet. (1989), 217:430-436-   Nonpatent Document 2: A. Oubrie et al. (1999) J. Mol. Biol., 289,    319-333-   Nonpatent Document 3: A. Oubrie et al. (1999) The EMBO Journal,    18(19), 5187-5194-   Nonpatent Document 4: A. Oubrie et al. (1999) PNAS, 96(21),    11787-11791

DISCLOSURE OF THE INVENTION

An object of the present invention is to provide a modifiedpyrroloquinoline quinone glucose dehydrogenase that exhibits a highselectivity for glucose.

The present inventor discovered that the selectivity for glucose isincreased by the insertion, in a particular position in water-solublePQQGDH, of a peptide fragment comprising 4 or 5 amino acids having apredetermined sequence.

The present invention provides a modified pyrroloquinoline quinoneglucose dehydrogenase in which the amino acid residue G at Position 99of a pyrroloquinoline quinone glucose dehydrogenase (PQQGDH) representedby SEQ ID NO: 1 or the amino acid residue G at Position 100 of thePQQGDH represented by SEQ ID NO: 3 is substituted by the amino acidsequence TGZN (where Z is SX, S, or N and X is any amino acid residue),and wherein from 1 to 10 of amino acid residues at Positions 1 to 98 andamino acid residues at Positions 100 to 478 of SEQ ID NO: 1, or aminoacid residues at Positions 1 to 99 and amino acid residues at Positions101 to 480 of SEQ ID NO: 3, may be substituted by any other amino acidresidue(s). Z in the modified pyrroloquinoline quinone glucosedehydrogenase of the present invention is preferably SX and isparticularly preferably SN.

Preferably, the modified pyrroloquinoline quinone glucose dehydrogenaseof the present invention further comprises one or more mutationsselected from the group consisting of the following amino acidsubstitutions:

Q192G, Q192A, or Q192S;

L193X (where X is any amino acid residue);

E277X (where X is any amino acid residue);

A318X (where X is any amino acid residue);

Y367A, Y367F, or Y367W;

G451C; and

N452X (where X is any amino acid residue).

In another aspect the present invention provides a gene coding for themodified pyrroloquinoline quinone glucose dehydrogenase according to thepresent invention, a recombinant vector comprising the gene, and atransformant or transfectant that has been transformed with therecombinant vector. The present invention further provides a method ofpreparing the modified pyrroloquinoline quinone glucose dehydrogenase,comprising culturing a transformant that was transformed by arecombinant vector comprising a gene coding for the modifiedpyrroloquinoline quinone glucose dehydrogenase according to the presentinvention; and recovering the modified pyrroloquinoline quinone glucosedehydrogenase from the culture.

In an additional aspect the present invention provides a glucose assaykit comprising the modified pyrroloquinoline quinone glucosedehydrogenase according to the present invention. The present inventionadditionally provides an enzyme electrode comprising the modifiedpyrroloquinoline quinone glucose dehydrogenase according to the presentinvention, as well as a glucose sensor comprising this enzyme electrodeas a working electrode.

The modified pyrroloquinoline quinone glucose dehydrogenase of thepresent invention exhibits a high selectivity for glucose as well as ahigh glucose oxidation activity, and can therefore be used for thehighly selective and highly sensitive assay of glucose.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows the enzymatic activity of the modified PQQGDH of thepresent invention for glucose and maltose.

PREFERRED EMBODIMENT OF THE INVENTION Structure of the Modified PQQGDH

The modified pyrroloquinoline quinone glucose dehydrogenase of thepresent invention is characterized in that the amino acid residue G atPosition 99 of the water-soluble PQQGDH shown by SEQ ID NO: 1 or theamino acid residue G at Position 100 of the PQQGDH shown by SEQ ID NO: 3is substituted by the amino acid sequence TGZN (where Z is SX, S, or Nand X is any amino acid residue). As used herein, the position of anamino acid in the amino acid sequence of the water-soluble PQQGDHs isnumbered by assigning 1 to the initiation methionine.

The PQQGDH represented by SEQ ID NO: 1 is a PQQGDH from Acinetobactercalcoaceticus (GenBank accession number X15871) and the PQQGDHrepresented by SEQ ID NO: 3 is a PQQGDH from Acinetobacter baumannii(GenBank accession number E28183). These PQQGDHs have an approximately92% homology at the level of the amino acid sequence. The alignment ofthe two sequences is shown below.

TABLE 1 _aln.pos         10        20        30        40        50        60 Calcoace MNKHLLAKIALLSAVQLVTL-SAFADVPLTPSQFAKAKSENFDKKVILSNLNKPHALLWGPDNQIWLT(SEQ ID NO: 1) Baumannii MNKHLLAKITLLGAAQLFTFHTAFADIPLTPAQFAKAKTENFDKKVILSNLNKPHALLWGPDNQIWLT(SEQ ID NO: 3) _consrvd ************ * ** *   * **** ****** *****************************_aln.p  70        80        90       100       110       120       130calocoace ERATGKILRVNPESGSVKTVFQVPEIVNDADGQNGLLGFAFHPDFKNNPYIYISGTFKNPKSTDBaumannii ERATGKILRVNPVSGSAKTVFQVPEIVSDADGQNGLLGFAFHPDFKHNPYIYISGTFKNPKSTD_consrvd ************ *** ********** ****************** *****************_aln.pos  140       150       160       170       180       190       200calcoace KELPNQTIIRRYTYNKSTDTLEKPVDLLAGLPSSKDHQSGRLVIGPDQKIYYTIGDQGRNQLAYLFLPBaumannii KELPNQTIIRRYTYNKTTDTFEKPIDLIAGLPSSKDHQSGRLVIGPDQKIYYTIGDQGRNQLAYLFLS_consrvd **************** *** *** ** ***************************************_aln.pos    210       220       230      240        250       260       270calcoace NQAQHTPTQQELNGKDYHTYMGKVLRLNLDGSIPKDNPSFNGVVSHIYTLGHRNPQGLAFTPNGKLLQBaumannii NQAQHTPTQQELNSKDYHTYMGKVLRLNLDGSIPKDNPSFNGVVSHIYTLGHRNPQGLAFAPNGKLLQ_consrvd ************* ********************************************** *******_aln.pos     280        290       300       310       320       330       340calcoace SENPNSDDE INLIVKGGNYGWPNVAGYKDDSGYAYANYSAAANK-SIKDLAQNGVKVAAGVPVTKESBaumannii SENPNSDDE INLVLKGGNYGWPNVAGYKDDSGYAYANYSAATNKSQIKDLAQNGIKVATGVPVTKES_consrvd *************  *************************** **  ******** *** ********_aln.pos         350       360       370       380       390       400calcoace EWTGKNFVPPLKTLYTVQDTYNYNDPTCGEMTYICWPTVAPSSAYVYKGGKKAITGWENTLLVPSLKRBaumannii EWTGKNFVPPLKTLYTVQCTYNYNDPTCGEMAYICWPTVAPSSAYVYTGGKKAIPGWENTLLVPSLKR_consrvd ******************************* *************** ****** *************_aln.p 410       420       430       440       450       460       470calcoace GVIFRIKLDPTYSTTYDDAVPMFKSNNRYRDVIASPDGNVLYVLTDTAGNVQKDDGSVTNTLENPGSLBaumannii GVIFRIKLDPTYSTTLDDAIPMFKSNNRYRDVIASPEGNTLYVLTDTAGNVQKDDGSVTHTLENPGSL_consrvd *************** *** **************** ** ******************* ********_aln.pos  480 calcoace  IKFTYKAK Baumannii  IKFTYNGK _consrvd  *****  *

These two PQQGDHs have similar secondary structures, and it is knownthat the properties of enzymes, for example, the thermal stability andsubstrate specificity, are similarly changed by the substitution ofcorresponding amino acid residues.

Z in the modified pyrroloquinoline quinone glucose dehydrogenase of thepresent invention is preferably SX and particularly preferably is SN.Thus, the amino acid sequence TGSXN, preferably TGSNN, and particularlypreferably TGSKN, TGSRN, or TGSWN is inserted in place of the amino acidresidue G at Position 99 in SEQ ID NO: 1 or in place of the amino acidresidue G at Position 100 in SEQ ID NO: 3. TGSN or TGNN is alsopreferably inserted in place of this amino acid residue G.

The modified PQQGDH of the present invention has a higher selectivityfor glucose than naturally occurring water-soluble PQQGDH. The modifiedPQQGDH of the present invention preferably has a lower reactivity formaltose versus reactivity for glucose than does the wild type. Given thereactivity for glucose is 100%, preferably the activity for maltose isnot more than 50%, more preferably not more than 30%, even morepreferably not more than 20%, and most preferably not more than 10%.

The modified PQQGDH of the present invention may have other mutations inaddition to the mutation in the amino acid residue at Position 99 of SEQID NO: 1 or at Position 100 of SEQ ID NO: 3. For example, one or more,for example, from 1 to 10, of the amino acid residues at Positions 1 to98 or at Positions 100 to 478 of SEQ ID NO: 1, or the amino acidresidues at Positions 1 to 99 or at Positions 101 to 480 of SEQ ID NO:3, may be substituted by any other amino acid residue.

In a preferred embodiment of the present invention, the modified PQQGDHof the present invention has one or more mutations, preferably from 1 to10 mutations, for example, 1, 2, 3, 4, 5, or 6 mutations, selected fromthe group consisting of

Q192G, Q192A, or Q192S;

L193X (where X is any amino acid residue);

E277X (where X is any amino acid residue);

A318X (where X is any amino acid residue);

Y367A, Y367F, or Y367W;

G451C; and

N452X (where X is any amino acid residue).

Wherein, the “Q192G” designation, for example, indicates that theglutamine at Position 192 in SEQ ID NO: 1, or the correspondingglutamine at Position 193 in SEQ ID NO: 3, is substituted by glycine.The other substitutional mutations are also indicated in the samemanner.

A particularly preferred embodiment of the present invention is amodified pyrroloquinoline quinone glucose dehydrogenase comprising anyof the following combinations of amino acid mutations:

G99(TGSXN)+Q192G+L193E;

G99(TGSXN)+Q192S+N452P;

G99(TGSXN)+Q192G+L193E+N452P;

G99(TGSXN)+Q192S+N452P;

G99(TGSNN)+N452P;

G99(TGSNN)+Q192G+L193E+N452P;

G99(TGSNN)+Q192S+N452P;

G99(TGSNN)+Q192G+N452P;

G99(TGSNN)+L193E+N452P;

G99(TGSNN)+Q192S+L193M+N452P;

G99(TGSNN)+A318Y+N452P;

G99(TGSNN)+Q192G;

G99(TGSNN)+Q192S;

G99(TGSNN)+Q192A;

G99(TGSNN)+Q192G+L193E;

G99(TGSNN)+Q192S+L193X;

G99(TGSNN)+Q192S+L193M;

G99(TGSNN)+Q192S+L193T;

G99(TGSNN)+Q192S+E277X;

G99(TGSNN)+Q192S+N452X;

G99(TGSNN)+Q192S+L193X+A318Y+N452P;

G99(TGSNN)+Q192S+A318X+N452P;

G99(TGSNN)+Q192G+L193E+A318X+N452P;

G99(TGSKN)+Q192S+N452P;

G99(TGSRN)+Q192S+N452P;

G99(TGSWN)+Q192S+N452P;

G99(TGSN)+Q192S+N452P;

G99(TGSN)+Q192G+L193E;

G99(TGSN)+Q192S+L193M;

G99(TGNN)+Q192S+N452P;

G99(TGNN)+Q192G+L193E; or

G99(TGNN)+Q192S+L193M.

Wherein X is any amino acid reside, for example, G99(TGSXN) indicatesthat the G at Position 99 in the PQQGDH represented by SEQ ID NO: 1 issubstituted by TGSXN.

Another preferred embodiment of the present invention is a modifiedpyrroloquinoline quinone glucose dehydrogenase comprising any of thefollowing amino acid mutations:

G99(TGSXN)+Q192G+L193E;

G99(TGSXN)+Q192S+N452P;

G99(TGSNN)+Q192G+L193E+N452P;

G99(TGSNN)+Q192S+L193M+N452P;

G99(TGSNN)+Q192G+L193E+A318K+N452P; or

G99(TGSNN)+Q192G+L193E+A318Q+N452P.

WO 04/005499 discloses that the glutamine residue at Position 192, theleucine residue at Position 193, and the asparagine residue at Position452 are involved in substrate recognition and binding by PQQGDH. Ingeneral, however, it is completely unpredictable how the substratespecificity and enzymatic activity will change when mutations aresimultaneously introduced in amino acid residues present in differentdomains. A complete loss of enzymatic activity may even occur in somecases. Accordingly, it was totally unpredictable if the selectivity forglucose would be further enhanced by the simultaneous introduction ofthe above-indicated substitutions and an insertion mutation at the aminoacid residue at Position 99 in SEQ ID NO: 1 or the amino acid residue atPosition 100 in SEQ ID NO: 3.

Method of Producing Modified PQQGDH

The sequence of the gene coding for naturally occurring water-solublePQQGDH from Acinetobacter calcoaceticus is shown in SEQ ID NO: 2, whilethe sequence of the gene coding for naturally occurring water-solublePQQGDH from Acinetobacter baumannii is shown in SEQ ID NO:4. A genecoding for the modified PQQGDH of the present invention can beconstructed by replacing the nucleotide sequence coding for the aminoacid residue targeted for substitution in the gene coding for naturallyoccurring water-soluble PQQGDH with a nucleotide sequence coding for thedesired amino acid residue. Methods for such a site-specific sequencesubstitution are well known in the art; for example, by PCR usingsuitably designed primers, as is described in the examples providedbelow.

The thus obtained mutant gene is inserted in an expression vector (forexample, a plasmid), which is then transformed into a suitable host (forexample, E. coli). A large number of vector/host systems for theexpression of foreign protein are known in the art. A variety of hosts,for example, bacteria, yeast, cultured cells, and so forth areavailable.

In addition, a portion of other amino acid residues in the modifiedPQQGDH of the present invention may also be deleted or substituted, andother amino acid residues may be added, insofar as it has a desiredglucose dehydrogenase activity. Various methods for site-specificnucleotide sequence substitution are well known in the art.

The modified PQQGDH-expressing transformant obtained as described aboveis then cultured, and the cells are recovered from the culture fluid by,for example, centrifugation. The recombinant protein present in vheperiplasmic compartment is subsequently released into culture medium bygrinding the cells, for example, with a French press, or by osmoticshock. Ultracentrifugation is thereafter carried out to obtain awater-soluble fraction containing the modified PQQGDH. Alternatively,through the use of a suitable host-vector system, the expressed modifiedPQQGDH can be secreted into the culture fluid. The modified PQQGDH ofthe present invention can be isolated by purifying the water-solublefraction by, for example, ion-exchange chromatography, affinitychromatography, HPLC, and so forth.

Method of Measuring the Enzymatic Activity

The modified PQQGDH of the present invention has the ability to catalyzethe oxidation of glucose with PQQ as its coenzyme, with the productionof gluconolactone. To measure the enzymatic activity, the quantity ofPQQ that is reduced accompanying the PQQGDH-mediated glucose oxidationcan be quantitated by the color reaction of a redox dye. For example,phenazine methosulfate (PMS), 2,6-dichlorophenolindophenol (DCIP),potassium ferricyanide, ferrocene, and so forth, can be used as thechromogenic reagent.

Selectivity for Glucose

The selectivity for glucose exhibited by the modified PQQGDH of thepresent invention can be evaluated by measuring the enzymatic activityin the manner described above using various sugars as substrates, e.g.,2-deoxy-D-glucose, mannose, allose, 3-o-methyl-D-glucose, galactose,xylose, lactose, maltose, and so forth, and determining the relativeactivity with reference to the activity using glucose as the substrate.

The modified PQQGDH of the present invention provides a higherselectivity for glucose than the wild-type enzyme and in particular hasa higher reactivity for glucose than for maltose. Accordingly, an assaykit or enzyme sensor constructed using the modified PQQGDH of thepresent invention will exhibit a high selectivity with regard to glucosemeasurement and offers the advantage of high-sensitivity glucosedetection even when a maltose-containing sample is used.

Glucose Assay Kit

Another aspect of the present invention is a glucose assay kitcomprising a modified PQQGDH according to the present invention. Theglucose assay kit of the present invention comprises the modified PQQGDHaccording to the present invention in a quantity sufficient forconducting at least one assay. In addition to the modified PQQGDH of thepresent invention, the kit will typically comprise a buffer required forthe assay, a mediator, a glucose reference solution for constructing acalibration curve, and instructions for use. The modified PQQGDHaccording to the present invention can be provided in various forms, forexample, as a freeze-dried reagent or as a solution in a suitablestorage solution. The modified PQQGDH of the present invention ispreferably provided in a form of holoenzyme, but can also be provided asthe apoenzyme and then converted into the holoenzyme before use.

Glucose Sensor

Additional aspect of the present invention is an enzyme electrode thatcarries a modified PQQGDH according to the present invention, and aglucose sensor comprising the enzyme electrode. For example, a carbonelectrode, gold electrode, or platinum electrode can be used as theelectrode, and the enzyme according to the present invention isimmobilized on the electrode. The immobilization method can beexemplified by the use of a crosslinking reagent; enclosure in a polymermatrix; coating with a dialysis film; use of a photocrosslinkingpolymer, electroconductive polymer, or redox polymer; immobilization ina polymer or adsorptive immobilization on the electrode together with anelectron mediator such as ferrocene and its derivatives; and the use ofcombinations of the preceding. The modified PQQGDH of the presentinvention is preferably immobilized on the electrode in a holoenzymeform, but can also be immobilized in an apoenzyme form with the PQQbeing provided in a separate layer or in a solution. Typically, themodified PQQGDH of the present invention is immobilized on a carbonelectrode via glutaraldehyde followed by treatment with an aminegroup-containing reagent to block the aldehyde groups of glutaraldehyde.

Measurement of the glucose concentration can be carried out as follows.Buffer solution is introduced into a thermostatted cell; PQQ, CaCl₂, anda mediator are added; and the cell is held at a constant temperature.Potassium ferricyanide, phenazine methosulfate, and so forth, may beused as the mediator. An electrode bearing the immobilized modifiedPQQGDH of the present invention is used as the working electrode, incombination with a counterelectrode (for example, a platinum electrode)and a reference electrode (for example, the Ag/AgCl electrode). Aconstant voltage is applied to the carbon electrode, and after thecurrent becomes constant, a glucose-containing sample is added and theincrease in the current is measured. The glucose concentration in thesample can be determined using a calibration curve constructed usingglucose solutions of standard concentrations.

The contents of all the patents and reference documents explicitly citedherein are hereby incorporated by reference in its entirety.

The present invention is described in detail based on the followingexamples, but is not limited to these examples.

Example 1 Construction of Modified PQQGDH-Encoding Genes

Mutation was introduced into the structural gene for water-solublePQQGDH from Acinetobacter calcoaceticus, which is represented by SEQ IDNO: 2. In brief, PCR was carried out using a full length forward primerfor the wild-type water-soluble PQQGDH and a mutagenic reverse primer,and another PCR was carried out using a full length reverse primer and amutagenic forward primer. These PCR products were mixed and PCR was runusing a full length forward primer and reverse primer to obtain a genecoding for the mutated full length PQQGDH. The product was sequenced toconform that the desired mutation was correctly introduced.

The sequence of the primers for full length amplification were asfollows.

(SEQ ID NO: 5) forward: AACAGACCATGGATAAACATTTATTGGC (SEQ ID NO: 6)reverse: ACAGCCAAGCTTTTACTTAGCCTTATAGG

The sequences of the mutagenic primers (F: forward, R: reverse) areshown in the following table.

TABLE 2 SEQ  Muta- ID tion Primer Sequence NO TGNNACTGGAAATAATCAGAATGGTTTATTAGGTTTT F 7 CTGATTATTTCCAGTATCAGCATCATTGACAATR 8 TGQN ACTGGACAGAATCAGAATGGTTTATTAGGTTTT F 9CTGATTCTGTCCAGTATCAGCATCATTGACAAT R 10 TGSNACTGGAAGCAATCAGAATGGTTTATTAGGTTTT F 11 CTGATTGCTTCCAGTATCAGCATCATTGACAATR 12 TGGN ACTGGAGGTAATCAGAATGGTTTATTAGGTTTT F 13CTGATTACCTCCAGTATCAGCATCATTGACAAT R 14 TGSSNGATACTGGAAGCAGCAATCAGAATGGTTTATTA F 15 ATTGCTGCTTCCAGTATCAGCATCATTGACAATR 16 TGWN ACTGGATGGAATCAGAATGGTTTATTAGGTTTT F 17CTGATTCCATCCAGTATCAGCATCATTGACAAT R 18 TGFNACTGGATTTAATCAGAATGGTTTATTAGGTTTT F 19 CTGATTAAATCCAGTATCAGCATCATTGACAATR 20 TGDN ACTGGAGATAATCAGAATGGTTTATTAGGTTTT F 21CTGATTATCTCCAGTATCAGCATCATTGACAAT R 22 TGSHNGATACTGGAAGCCATAATCAGAATGGTTTATTA F 23 ATTATGGCTTCCAGTATCAGCATCATTGACAATR 24 TGSLN GATACTGGAAGCTTAAATCAGAATGGTTTATTA F 25ATTTAAGCTTCCAGTATCAGCATCATTGACAAT R 26 TGSVNGATACTGGAAGCGTCAATCAGAATGGTTTATTA F 27 ATTGACGCTTCCAGTATCAGCATCATTGACAATR 28 TGSQN GATACTGGAAGCCAAAATCAGAATGGTTTATTA F 29ATTTTGGCTTCCAGTATCAGCATCATTGACAAT R 30 TGSENGATACTGGAAGCGAAAATCAGAATGGTTTATTA F 31 ATTTTCGCTTCCAGTATCAGCATCATTGACAATR 32 TGSDN GATACTGGAAGCGATAATCAGAATGGTTTATTA F 33ATTATCGCTTCCAGTATCAGCATCATTGACAAT R 34 TGSPNGATACTGGAAGCCCTAATCAGAATGGTTTATTA F 35 ATTAGGGCTTCCAGTATCAGCATCATTGACAATR 36 TGSTN GATACTGGAAGCACAAATCAGAATGGTTTATTA F 37ATTTGTGCTTCCAGTATCAGCATCATTGACAAT R 38 TGSINGATACTGGAAGCATTAATCAGAATGGTTTATTA F 39 ATTAATGCTTCCAGTATCAGCATCATTGACAATR 40 TGSAN GATACTGGAAGCGCTAATCAGAATGGTTTATTA F 41ATTAGCGCTTCCAGTATCAGCATCATTGACAAT R 42 TGSWNGATACTGGAAGCTGGAATCAGAATGGTTTATTA F 43 ATTCCAGCTTCCAGTATCAGCATCATTGACAATR 44 TGSGN GATACTGGAAGCGGTAATCAGAATGGTTTATTA F 45ATTACCGCTTCCAGTATCAGCATCATTGACAAT R 46 TGSFNGATACTGGAAGCTTTAATCAGAATGGTTTATTA F 47 ATTAAAGCTTCCAGTATCAGCATCATTGACAATR 48 TGSYN GATACTGGAAGCTATAATCAGAATGGTTTATTA F 49ATTATAGCTTCCAGTATCAGCATCATTGACAAT R 50 TGSCNGATACTGGAAGCTGCAATCAGAATGGTTTATTA F 51 ATTGCAGCTTCCAGTATCAGCATCATTGACAATR 52 TGSMN GATACTGGAAGCATGAATCAGAATGGTTTATTA F 53ATTCATGCTTCCAGTATCAGCATCATTGACAAT R 54 TGSKNGATACTGGAAGCAAAAATCAGAATGGTTTATTA F 55 ATTTTTGCTTCCAGTATCAGCATCATTGACAATR 56 TGSRN GATACTGGAAGCCGTAATCAGAATGGTTTATTA F 57ATTACGGCTTCCAGTATCAGCATCATTGACAAT R 58 TGSNNGATACTGGAAGCAATAATCAGAATGGTTTATTA F 59 ATTATTGCTTCCAGTATCAGCATCATTGACAATR 60

Other substitutional mutations, e.g., mutations such as Q192G and L193Ewere introduced using conventional site-specific mutagenesis methods asdescribed in WO 00/66744. In addition, modified PQQGDHs thatincorporated a combination of mutations at a plurality of sites wereprepared by site-specific mutagenesis using a plurality of primers thatcorresponded to the individual mutations or were prepared by arecombinant method using restriction enzymes.

Example 2 Production of Modified PQQGDH

The gene coding for wild-type PQQGDH or the gene coding for the modifiedPQQGDH constructed as described above was inserted in the multicloningsite of an E. coli expression vector pTrc99A (Pharmacia), and theconstructed plasmid was transformed into E. coli. The transformant wascultured with shaking overnight at 37° C. in 450 mL L-broth containing50 μg/mL ampicillin and 30 μg/mL chloramphenicol. The culture wasinoculated into 7 L of L-broth containing 1 mM CaCl₂ and 500 μM PQQ. Atapproximately 3 hours after the start of cultivation,isopropylthiogalactoside was added at a final concentration of 0.3 mMand continued cultivation for 1.5 hours. The cells were recovered fromthe culture medium by centrifugation (5000×g, 10 minutes, 4° C.) andsuspended in 150 μL 10 mM MOPS (pH 7.0). Glass beads (0.105 to 0.125 mmfor bacteria) were added in an amount that was ½ to ⅔ of the volume andvortexed for 20 minutes at 4° C. 1 mL 10 mM MOPS (pH 7.0) was added andcentrifuged (15,000 rpm, 20 minutes, 4° C.). The supernatant wascollected and used as a crude enzyme preparation in the followingexamples.

Example 3 Measurement of the Enzymatic Activity

900 μL of a mixture of 10 mM MOPS (pH 7.0)+1 mM PQQ+1 mM CaCl₂holoenzyme conversion solution was added to 100 μL of the crude enzymepreparation of the wild-type PQQGDH or the modified PQQGDH obtained inExample 2 and left stand (room temperature, in the dark, at least 30minutes) to allow for conversion to the holoenzyme. After completion ofconversion to the holoenzyme, the solution was diluted 10× to prepare anenzyme test solution. To 150 μL of the enzyme test solution was added 50μL of a given concentration of the substrate (glucose or maltose), 0.6mM phenazine methosulfate (PMS), and 0.3 mM 2,6-dichlorophenolindophenol(DCIP, final concentrations in each case), and incubated at roomtemperature in the total volume of 200 μL. Glucose and maltose were usedas the substrates at final concentrations of 0, 1, 2, 4, 10, 20, and 40mM. The change in the DCIP absorbance at 600 nm was monitored with aspectrophotometer. The rate of decline in the absorbance was measured todetermine the reaction rate of the enzyme. In the experiments describedherein, 1 unit was designated as the enzymatic activity that reduces 1μmol of DCIP in 1 minute with the molar absorption coefficient of 16.3mM⁻¹ of DCIP at pH 7.0. The protein concentration was measured using acommercially available protein assay kit (BioRad).

Typical results are given in the following tables indicated by the ratio(%) of the activity for 4 mM maltose with reference to the activity for4 mM glucose.

TABLE 3 TGSXN Wild Type 79 Q192G + 193E 9.0 TGSAN 54 TGSCN 47 TGSDN 60TGSEN 51 TGSGN 52 TGSHN 46 TGSIN 42 TGSKN 43 TGSMN 43 TGSNN 42 TGSPN 47TGSQN 42 TGSRN 43 TGSSN 57 TGSTN 47 TGSVN 39 TGSWN 33 TGSFN 58 TGSLN 49TGSYN 63

TABLE 4 TGSXN + Q192G + L193E Wild Type 79 Q192G + L193E 9.0 TGSGN +Q192G + L193E 6.7 TGSMN + Q192G + L193E 5.7 TGSNN + Q192G + L193E 4.2TGSPN + Q192G + L193E 6.6 TGSQN + Q192G + L193E 5.2 TGSRN + Q192G +L193E 6.0 TGSSN + Q192G + L193E 9.3 TGSTN + Q192G + L193E 7.4 TGSVN +Q192G + L193E 6.9 TGSAN + Q192G + L193E 15 TGSDN + Q192G + L193E 16TGSEN + Q192G + L193E 20 TGSHN + Q192G + L193E 9.8 TGSIN + Q192G + L193E20 TGSKN + Q192G + L193E 5.7 TGSCN + Q192G + L193E 17 TGSWN + Q192G +L193E 7.6

TABLE 5 TGSNN + Q192S + E277X TGSNN + Q192S 12 TGSNN + Q192S + E277A 20TGSNN + Q192S + E277D 26 TGSNN + Q192S + E277I 15 TGSNN + Q192S + E277T22 TGSNN + Q192S + E277Q 16 TGSNN + Q192S + E277V 23 TGSNN + Q192S +E277W 38 TGSNN + Q192S + E277Y 27 TGSNN + Q192S + E277C 12 TGSNN +Q192S + E277F 66 TGSNN + Q192S + E277G 34 TGSNN + Q192S + E277H 39TGSNN + Q192S + E277K 29 TGSNN + Q192S + E277L 76 TGSNN + Q192S + E277M64 TGSNN + Q192S + E277N 56 TGSNN + Q192S + E277S 13 TGSNN + Q192S +E277R 24 TGSNN + Q192S + E277P 39

TABLE 6 TGSNN + Q192S + N452X TGSNN + Q192S + N452A 8.9 TGSNN + Q192S +N452C 12 TGSNN + Q192S + N452D 20 TGSNN + Q192S + N452E nd TGSNN +Q192S + N452F 10 TGSNN + Q192S + N452G 14 TGSNN + Q192S + N452H 13TGSNN + Q192S + FN452I 14 TGSNN + Q192S + N452K 18 TGSNN + Q192S + N452L7.8 TGSNN + Q192S + N452M 11 TGSNN + Q192S + N452P 1.9 TGSNN + Q192S +N452Q nd TGSNN + Q192S + N452R 27 TGSNN + Q192S + N452S 11 TGSNN +Q192S + N452T 14 TGSNN + Q192S + N452V 8.8 TGSNN + Q192S + N452W 79TGSNN + Q192S + N452Y 9.3

TABLE 7 TGSNN + Q192G/S/A Wild Type 79 Q192G + L193E 9.0 TGSNN + Q192G +L193E 4.2 Q192G 20 TGSNN + Q192G 9.1 Q192A 15 TGSNN + Q192A 7.8 Q192S 28TGSNN + Q192S 12

TABLE 8 TGSNN + Q192S + L193X TGSNN + Q192S 12 TGSNN + Q192G + L193E 4.2TGSNN + Q192S + L193G 6.8 TGSNN + Q192S + L193A 7.3 TGSNN + Q192S +L193K 3.7 TGSNN + Q192S + L193R 7.7 TGSNN + Q192S + L193H 8.3 TGSNN +Q192S + L193D 6.8 TGSNN + Q192S + L193E 4.3 TGSNN + Q192S + L193N 8.9TGSNN + Q192S + L193Q 11 TGSNN + Q192S + L193S 5.7 TGSNN + Q192S + L193T6.3 TGSNN + Q192S + L193Y 7.4 TGSNN + Q192S + L193C 9.3 TGSNN + Q192S +L193M 4.0 TGSNN + Q192S + L193F 7.8 TGSNN + Q192S + L193W 8.2 TGSNN +Q192S + L193V 7.0 TGSNN + Q192S + L193I 6.9 TGSNN + Q192S + L193P 6.1

TABLE 9 Wild Type 79 TGSNN 42 TGSNN + Q192S 12 TGSNN + N452P 14 TGSNN +Q192G + L193E 4.2 TGSNN + Q192S + L193M 4.0 TGSNN + Q192S + L193T 5.8TGSNN + Q192S + N452P 1.9 TGSNN + Q192G + N452P 1.6 TGSNN + Y367A +N452P 50 TGSNN + Y367F + N452P 12 TGSNN + Y367W + N452P 15 TGSNN +Q192S + Y367A + N452P nd TGSNN + Q192S + Y367F + N452P 2.7 TGSNN +Q192S + Y367W + N452P 2.0 TGSNN + L193E + N452P 1.0 TGSNN + Q192G +L193E + N452P 0.6

TABLE 10 Wild Type 79 G451C 74 TCSRN 33 TCSRN + G451C 44 N452P 30TGSNN + Q192S + L193M 4.0 TGSNN + Q192S + L193M + N452P 0.8 TGSNN +Q192G + L193E + E277K 2.7 TGSNN + Q192G + L193E + N452P 0.6 TGSNN +N452P 14 TGSNN + A318Y + N452P 7.8

TABLE 11 TGSXN + Q192S + N452P TGSAN + Q192S + N452P 7.6 TGSCN + Q192S +N452P 3.9 TGSDN + Q192S + N452P 3.6 TGSFN + Q192S + N452P 26 TGSGN +Q192S + N452P 3.6 TGSLN + Q192S + N452P 2.2 TGSMN + Q192S + N452P 2.5TGSNN + Q192S + N452P 1.9 TGSPN + Q192S + N452P 19 TGSSN + Q192S + N452P7.4 TGSTN + Q192S + N452P 3.8 TGSVN + Q192S + N452P 3.7 TGSIN + Q192S +N452P 3.4 TGSWN + Q192S + N452P 1.2 TGSYN + Q192S + N452P 1.4 TGSEN +Q192S + N452P 5.8 TGSHN + Q192S + N452P 4.0 TGSQN + Q192S + N452P 5.1TGSRN + Q192S + N452P 1.5

TABLE 12 TGSXN + Q192G + L193E + N452P TGSAN + Q192G + L193E + N452P 4.1TGSFN + Q192G + L193E + N452P nd TGSHN + Q192G + L193E + N452P 2.3TGSIN + Q192G + L193E + N452P 1.6 TGSLN + Q192G + L193E + N452P 1.4TGSNN + Q192G + L193E + N452P 0.6 TGSQN + Q192G + L193E + N452P 8.4TGSTN + Q192G + L193E + N452P nd TGSVN + Q192G + L193E + N452P 2.3TGSCN + Q192G + L193E + N452P 44 TGSDN + Q192G + L193E + N452P 7.2TGSMN + Q192G + L193E + N452P 7.3 TGSKN + Q192G + L193E + N452P 2.4TGSPN + Q192G + L193E + N452P 5.4 TGSRN + Q192G + L193E + N452P 3.1TGSSN + Q192G + L193E + N452P 5.2 TGSWN + Q192G + L193E + N452P 2.7TGSYN + Q192G + L193E + N452P 3.1

TABLE 13 TGSXN + Q192S + N452P TGSNN 42 TGSKN 43 TGSRN 43 TGSWN 33TGSNN + Q192S 12 TGSKN + Q192S 14 TGSRN + Q192S 8.1 TGSWN + Q192S 7.2TGSNN + N452P 14 TGSKN + N452P 16 TGSRN + N452P 15 TGSWN + N452P 10TGSNN + Q192S + N452P 1.9 TGSKN + Q192S + N452P 1.8 TGSRN + Q192S +N452P 1.5 TGSWN + Q192S + N452P 1.2

TABLE 14 TGSNN + Q192S + L193X + A318Y + N452P TGSNN + Q192S + L193M +N452P 0.8 TGSNN + Q192S + A318Y + N452P 1.5 TGSNN + Q192S + L193G +A318Y + N452P 1.0 TGSNN + Q192S + L193A + A318Y + N452P 8.8 TGSNN +Q192S + L193K + A318Y + N452P 0.5 TGSNN + Q192S + L193R + A318Y + N452P8.8 TGSNN + Q192S + L193H + A318Y + N452P 9.0 TGSNN + Q192S + L193D +A318Y + N452P 7.8 TGSNN + Q192S + L193E + A318Y + N452P 6.6 TGSNN +Q192S + L193N + A318Y + N452P 1.4 TGSNN + Q192S + L193Q + A318Y + N452P2.2 TGSNN + Q192S + L193S + A318Y + N452P 1.0 TGSNN + Q192S + L193T +A318Y + N452P 8.5 TGSNN + Q192S + L193Y + A318Y + N452P 8.1 TGSNN +Q192S + L193C + A318Y + N452P 8.9 TGSNN + Q192S + L193M + A318Y + N452P2.4 TGSNN + Q192S + L193F + A318Y + N452P 8.4 TGSNN + Q192S + L193W +A318Y + N452P 9.0 TGSNN + Q192S + L193V + A318Y + N452P 0.9 TGSNN +Q192S + L193I + A318Y + N452P 7.7 TGSNN + Q192S + L193P + A318Y + N452P8.2

TABLE 15 TGSNN + Q192S + A318X + N452P TGSNN + Q192S + N452P 1.9 TGSNN +Q192S + A318G + N452P 2.6 TGSNN + Q192S + A318K + N452P 0.0 TGSNN +Q192S + A318R + N452P 3.0 TGSNN + Q192S + A318H + N452P 2.0 TGSNN +Q192S + A318D + N452P 2.1 TGSNN + Q192S + A318E + N452P 2.3 TGSNN +Q192S + A318N + N452P 2.4 TGSNN + Q192S + A318Q + N452P 2.8 TGSNN +Q192S + A318S + N452P nd TGSNN + Q192S + A318T + N452P 5.1 TGSNN +Q192S + A318Y + N452P 2.3 TGSNN + Q192S + A318C + N452P nd TGSNN +Q192S + A318M + N452P 3.0 TGSNN + Q192S + A318F + N452P 3.0 TGSNN +Q192S + A318W + N452P 0.1 TGSNN + Q192S + A318V + N452P 0.4 TGSNN +Q192S + A318L + N452P 3.0 TGSNN + Q192S + A318I + N452P 4.5 TGSNN +Q192S + A318P + N452P nd

TABLE 16 TGSNN + Q192G + L193E + A318X + N452P TGSNN + Q192G + L193E +N452P 0.6 TGSNN + Q192G + L193E + A318G + N452P 0.7 TGSNN + Q192G +L193E + A318K + N452P 0.7 TGSNN + Q192G + L193E + A318R + N452P 0.7TGSNN + Q192G + L193E + A318H + N452P 0.8 TGSNN + Q192G + L193E +A318D + N452P 1.0 TGSNN + Q192G + L193E + A318E + N452P 0.9 TGSNN +Q192G + L193E + A318N + N452P 0.6 TGSNN + Q192G + L193E + A318Q + N452P0.5 TGSNN + Q192G + L193E + A318S + N452P 0.6 TGSNN + Q192G + L193E +A318T + N452P nd TGSNN + Q192G + L193E + A318Y + N452P 1.0 TGSNN +Q192G + L193E + A318C + N452P 0.7 TGSNN + Q192G + L193E + A318M + N452P0.5 TGSNN + Q192G + L193E + A318F + N452P 0.8 TGSNN + Q192G + L193E +A318W + N452P 1.0 TGSNN + Q192G + L193E + A318V + N452P nd TGSNN +Q192G + L193E + A318L + N452P 0.6 TGSNN + Q192G + L193E + A318I + N452P1.9 TGSNN + Q192G + L193E + A318P + N452P nd

TABLE 17 TGSI(K, R, W)N TGSNN 42 TGSKN 43 TGSRN 43 TGSWN 33 TGSNN +Q192S 12 TGSKN + Q192S 14 TGSRN + Q192S 8.1 TGSWN + Q192S 7.2 TGSNN +N452P 14 TGSKN + N452P 16 TGSRN + N452P 15 TGSWN + N452P 10 TGSNN +Q192S + N452P 1.9 TGSKN + Q192S + N452P 1.8 TGSRN + Q192S + N452P 1.5TGSWN + Q192S + N452P 1.2

TABLE 18 TGSN TGSN nd TGSN + N452P 38 TGSN + Q192S + N452P 9.5 TGSN +Q192G + L193E 11 TGSN + Q192G + L193E + N452P 2.5 TGSN + Q192S + L193M16 TGSN + Q192S + L193M + N452P 5.5

TABLE 19 TGNN TGNN 38 TGNN + N452P 22 TGNN + Q192S + N452P 5.3 TGNN +Q192G + L193E 11 TGNN + Q192G + L193E + N452P 2.1 TGNN + Q192S + L193M17 TGNN + Q192S + L193M + N452P 2.3

As is clear from the tables, the modified PQQGDH of the presentinvention in all cases exhibited a reactivity for glucose that washigher than that for maltose.

Example 4 Fabrication and Evaluation of an Enzyme Sensor

20 mg carbon paste was added to 5 units of the modified PQQGDH of thepresent invention and freeze-dried. After thorough mixing, it was filledonto the surface of a carbon paste electrode that carries approximately40 mg carbon paste, and polished on filter paper. The electrode wastreated for 30 minutes at room temperature in 10 mM MOPS buffer (pH 7.0)containing 1% glutaraldehyde, and then treated for 20 minutes at roomtemperature in 10 mM MOPS buffer (pH 7.0) containing 20 mM lysine inorder to block the glutaraldehyde. The electrode was equilibrated for atleast one hour at room temperature in 10 mM MOPS buffer (pH 7.0). Theelectrode was stored at 4° C.

The glucose concentration was measured using the enzyme sensor preparedabove. Glucose was quantitatively measured in the range from 0.1 mM to 5mM using the enzyme sensor having immobilized the modified PQQGDH of thepresent invention.

Example 5 Measurement of the Enzymatic Activity Using a Purified EnzymePreparation

A cation-exchange chromatography column packed with TSKgel CM-TOYOPEARL650M (Tosoh Corporation) was equilibrated with 10 mM phosphate buffer atpH 7.0 and the wild-type crude enzyme or the modified PQQGDH crudeenzymes obtained in Example 2 was adsorbed on the column. The column waswashed with 750 mL 10 mM phosphate buffer (pH 7.0) and the enzyme wasthen eluted with 10 mM phosphate buffer (pH 7.0) containing from 0 to0.2 M NaCl. The flow rate was 5 mL/minute. The fraction exhibiting GDHactivity was collected and was dialyzed overnight against 10 mMMOPS-NaOH buffer (pH 7.0) to obtain an electrophoretically-homogeneousmodified PQQGDH protein. The enzymatic activity of the purified enzymepreparations for glucose and maltose was measured as in Example 4.Typical results are shown in the following table.

TABLE 20 ENZYMATIC ACTIVITY Mal:Glu (Glu; 4 mM) (%) MODIFIED PQQGDH(U/mg) 4:4 40:4 TGSNN + Q192G + L193E 357 4.1 28* TGSNN + Q192S + N452P723 3.5 19* TGSNN + Q192G + L193E + N452P 213 0.56   5.7 TGSNN + Q192S +L193M + N452P 285 2.0 16* TGSNN + Q192G + L193E + A318K + 381 0.99  8.92 N452P TGSNN + Q192G + L193E + A318Q + 469 0.55   6.74 N452P*measured at Mal:Glu = 50:5

In addition, the enzymatic activity for glucose and maltose of themodified PQQGDH having the TGSNN+Q192G+L193E+N452P mutations is shown inFIG. 1.

Example 6 Comparison with Prior-Art Modified PQQGDHs

The enzymatic activity for glucose and maltose was measured as inExample 4 using the wild-type crude enzyme obtained in Example 2, themodified PQQGDH crude enzymes obtained in Example 2, and, forcomparison, prior-art modified PQQGDHs lacking the mutation at aminoacid residue G at Position 99 of PQQGDH but having the 1 or 2 or moreamino acid substitutions at other positions.

The following table shows typical results for the enzymatic activity ofthe modified PQQGDH of the present invention having various mutationsand substitution of 99G with TGSNN, a comparative PQQGDH having the samemutation(s) but not substitution at 99G and wild-type PQQGDH. Theresults are expressed by the activity for 4 mM glucose or 10 mM glucoseand for the ratio of the activity for maltose to the activity forglucose (%, 4 mM maltose: 4 mM glucose or 10 mM: 10 mM).

TABLE 21 ACTIVITY FOR Mal/Glu GLUCOSE (U/mg) (%) 4 mM 10 mM 4:4 10:10WILD TYPE 47.69 86.96 73.5 75.5 TGSNN + Q192G + L193E 10.63 20.20 4.25.1 Q192G + L193E 6.11 11.62 9.0 10.5 TGSNN + Q192G 15.90 26.36 9.1 11.9Q192G 19.30 31.79 20.2 26.1 TGSNN + Q192A 26.26 48.56 7.8 9.9 Q192A21.44 41.32 15.2 18.2 TGSNN + Q192S 35.83 60.94 12.9 17.0 Q192S 26.6644.91 28.0 37.8 TGSNN + N452P 58.71 110.01 16.3 18.7 N452P 56.53 103.4326.4 33.1 TGSNN + Q192S + N452P 37.98 72.23 1.5 2.2 Q192S + N452P 28.9356.12 5.0 6.6

As shown in the table, the enzymatic activity of the modified enzymesaccording to the present invention with the insertion of the TGSNNsequence for glucose is either maintained or increased compared to thecorresponding modified enzymes having the same mutations but lacking theinsertion of TGSNN. In addition, the maltose-versus-glucose activityratio is reduced to about one-half to one-fifth, and the selectivity forglucose is thus improved. For example, it has already been reported thatthe substrate specificity is increased in the modified PQQGDH having adouble mutation Q192G/L193E. The activity of the Q192G/L193E modifiedPQQGDH for 4 mM glucose was 6.1 U/mg and the 4 mM maltose-versus-4 mMglucose activity ratio was 9%. In contrast, the additional insertion ofTGSNN provided an approximately 1.7-fold increase in the activity for 4mM glucose to 10.63 U/mg, and a 2.14-fold increase in substratespecificity, with 4.2% for the 4 mM maltose-versus-4 mM glucose activityratio.

As demonstrated by these results, the modified PQQGDH of the presentinvention has a high enzymatic activity for glucose and a high substratespecificity for glucose over maltose.

INDUSTRIAL APPLICABILITY

The present invention is useful for assaying glucose and particularlyfor measuring blood sugar level.

The invention claimed is:
 1. A method of analyzing glucose level using amodified pyrroloquinoline quinone glucose dehydrogenase (PGGGDH),wherein the amino acid residue G at Position 100 of the PQQGDHrepresented by SEQ ID NO: 3 is substituted by the amino acid sequenceTGZN where Z is SX, S, or N, and X is any amino acid residue, andoptionally from 1 to 10 of amino acid residues at Positions 1 to 99 orat Positions 101 to 480 of SEQ ID NO: 3, are substituted with any otheramino acid residue(s).
 2. The method according to claim 1, wherein Z isSX where X is any amino acid residue.
 3. The method according to claim1, wherein Z is SN.
 4. The method according to claim 1, wherein saidfrom 1 to 10 of amino acid residues are substituted with one or moresubstitutions selected from the group consisting of the following aminoacid substitutions: (i) Q193G, Q193A, or Q193S ; L194X where X is anyamino acid residue; E278X where X is any amino acid residue; A320X whereX is any amino acid residue; (ii) Y369A, Y369F, or Y369W; (iii) G453C;and (iv) N454X where X is any amino acid residue.
 5. The methodaccording to claim 4, wherein the modified PGGGDH comprises any of thefollowing combinations of amino acid substitutions:G100(TGSXN)+Q193G+L194E; G100(TGSXN)+Q193S+N454P;G100(TGSXN)+Q193G+L194E+N454P; G100(TGSXN)+Q193S+N454P;G100(TGSNN)+N454P; G100(TGSNN)+Q193G+L194E+N454P;G100(TGSNN)+Q193S+N454P; G100(TGSNN)+Q193G+N454P;G100(TGSNN)+L194E+N454P; G100(TGSNN)+Q193S+L194M+N454P;G100(TGSNN)+A320Y+N454P; G100(TGSNN)+Q193G; G100(TGSNN)+Q193S;G100(TGSNN)+Q193A; G100(TGSNN)+Q193G+L194E; G100(TGSNN)+Q193S+L194X;G100(TGSNN)+Q193S+L194M; G100(TGSNN)+Q193S+L194T;G100(TGSNN)+Q193S+E278X; G100(TGSNN)+Q193S+N454X;G100(TGSNN)+Q193S+L194X+A320Y+N454P; G100(TGSNN)+Q193S+A320X+N454P;G100(TGSNN)+Q193G+L194E+A320X+N454P; G100(TGSKN)+Q193S+N454P;G100(TGSRN)+Q193S+N454P; G100(TGSWN)+Q193S+N454P;G100(TGSN)+Q193S+N454P; G100(TGSN)+Q193G+L194E; G100(TGSN)+Q193S+L194M;G100(TGNN)+Q193S+N454P; G100(TGNN)+Q193G+L194E; orG100(TGNN)+Q193S+L194M where X is any amino acid residue.
 6. The methodaccording to claim 5, wherein the modified PGGGDH comprises any of thefollowing combinations of amino acid substitutions:G100(TGSXN)+Q193G+L194E; G100(TGSXN)+Q193S+N454P;G100(TGSNN)+Q193G+L194E+N454P; G100(TGSNN)+Q193S+L194M+N454P;G100(TGSNN)+Q193G+L194E+A320K+N454P; orG100(TGSNN)+Q193G+L194E+A320Q+N454P.